Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Rein

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Acta Psychiatrica Scandinavica. Supplementum|May 24, 2000
Safety profile of amisulpride in short- and long-term useW Rein, C Coulouvrat, L Dondey-Nouvel
The American Journal of Psychiatry|April 14, 1999
Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study GroupJ M Danion, W Rein, O Fleurot
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 5, 2021
Connexins as therapeutic targets in neurological and neuropsychiatric disordersM Charvériat, F Mouthon, W Rein, et al.
Journal of Affective Disorders|April 1, 1997
Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study GroupY Lecrubier, P Boyer, S Turjanski, et al.
European Journal of Neurology|April 29, 2006
Skin biopsy findings and results of neuropsychological testing in the first confirmed cases of CADASIL in NorwayW Rein Gustavsen, F P Reinholt, A Schlosser
Acta Psychiatrica Belgica|July 1, 1982
[Introduction to the Seminar of the Association of Methodology and Documentation in Psychiatry in honor of Jean Bobon]C Mormont, D Bobon, R von Frenckell, et al.
International Clinical Psychopharmacology|June 3, 2000
Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study GroupL Colonna, P Saleem, L Dondey-Nouvel, et al.
Psychopharmacology|August 1, 1997
Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol. PROD-ASLP Study GroupH J Möller, P Boyer, O Fleurot, et al.
Pharmacopsychiatria|September 1, 1983
Prediction and evaluation criteria in perazine therapy of acute schizophrenics. Methodological considerations, sample population, and research variablesW Rein, H W Schied, U Breyer-Pfaff, et al.
European Archives of Psychiatry and Neurological Sciences|January 1, 1986
Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levelsH Giedke, H Gaertner, U Breyer-Pfaff, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Acta Psychiatrica Scandinavica. Supplementum|May 24, 2000
Safety profile of amisulpride in short- and long-term useW Rein, C Coulouvrat, L Dondey-Nouvel
The American Journal of Psychiatry|April 14, 1999
Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study GroupJ M Danion, W Rein, O Fleurot
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 5, 2021
Connexins as therapeutic targets in neurological and neuropsychiatric disordersM Charvériat, F Mouthon, W Rein, et al.
Journal of Affective Disorders|April 1, 1997
Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study GroupY Lecrubier, P Boyer, S Turjanski, et al.
European Journal of Neurology|April 29, 2006
Skin biopsy findings and results of neuropsychological testing in the first confirmed cases of CADASIL in NorwayW Rein Gustavsen, F P Reinholt, A Schlosser
Acta Psychiatrica Belgica|July 1, 1982
[Introduction to the Seminar of the Association of Methodology and Documentation in Psychiatry in honor of Jean Bobon]C Mormont, D Bobon, R von Frenckell, et al.
International Clinical Psychopharmacology|June 3, 2000
Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study GroupL Colonna, P Saleem, L Dondey-Nouvel, et al.
Psychopharmacology|August 1, 1997
Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol. PROD-ASLP Study GroupH J Möller, P Boyer, O Fleurot, et al.
Pharmacopsychiatria|September 1, 1983
Prediction and evaluation criteria in perazine therapy of acute schizophrenics. Methodological considerations, sample population, and research variablesW Rein, H W Schied, U Breyer-Pfaff, et al.
European Archives of Psychiatry and Neurological Sciences|January 1, 1986
Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levelsH Giedke, H Gaertner, U Breyer-Pfaff, et al.
Pageof 3